Session Information
-
WCLC 2019
2019 World Conference on Lung Cancer
Conference Program for the 2019 World Conference on Lung Cancer in Barcelona, Spain
Presentation Date(s):- Sept 7 - 10, 2019
- Total Presentations: 2970
September 7 Sat
Sep 7 Sunday
September 8 Sun
Sep 8 Monday
September 9 Mon
Sep 9 Tuesday
September 10 Tue
Sep 10
-
+
MA02 - Miscellaneous Topics in the Management of Early Stage Lung Cancer
- 10:30 - 12:00
- 9/08/2019
- Location: Interlaken (1988)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Treatment of Early Stage/Localized Disease
- Moderators:Mireia Serra-Mitjans, Thomas A. D'Amico
-
+
MA02.01 - Reccurrence Pattern After Adjuvant Customized Chemotherapy Based on BRCA Expression Level (SCAT Trial)
10:30 - 10:35 | Presenter: Bartomeu Massuti | Author(s): José Miguel Sanchez, Manuel Cobo, Teresa Moran, Jose Luis Gonzalez Larriba, Isidoro Barneto, Javier De Castro Carpeno, Lara Iglesias, Miguel Angel Muñoz, Guillermo López-Vivanco, Dolores Isla, Rafael López, Ramon De Las Penas, Delvys Rodriguez-Abreu, Angel Artal, Emilio Esteban, Mariano Provencio, Eva Pereira, Jose Sanchez-Payá, Rafael Rosell
- Abstract
Loading... -
+
MA02.02 - Toxicity of Lung SABR in Patients with Coexisting Interstitial Lung Disease
10:35 - 10:40 | Presenter: Tobias Finazzi | Author(s): Merle Ronden, Esther Nossent, Hilâl Tekatli, Idris Bahce, Ben Slotman, Femke Spoelstra, Suresh Senan
- Abstract
Loading... -
+
MA02.03 - Impact of Coexisting Interstitial Lung Disease on Resected Non-Small Cell Lung Cancer Patients
10:40 - 10:45 | Presenter: Jin Gu Lee | Author(s): Seong Yong Park, Chang Young Lee, Kyoung Shik Narm, Seung Hwan Song
- Abstract
Loading... -
+
MA02.04 - Discussant - MA02.01, MA02.02, MA02.03
10:45 - 11:00 | Presenter: Yaxing Shen
- Abstract
No abstract available for this presentation
-
+
MA02.05 - Patient Selection and Early Clinical Outcomes of MR-Guided SABR in 54 Lung Tumors
11:00 - 11:05 | Presenter: Tobias Finazzi | Author(s): Cornelis Haasbeek, Femke Spoelstra, Miguel Palacios, Marjan Admiraal, Anna Bruynzeel, Ben Slotman, Frank Lagerwaard, Suresh Senan
- Abstract
Loading... -
+
MA02.06 - Dose-Volume Factors Predicting Airway Stenosis After SBRT for Ultra-Central Lung Tumors
11:05 - 11:10 | Presenter: Andrew Jackson | Author(s): Chunyu Wang, Ellen Yorke, Daphna Geldblum, Aditya Apte, Jie Yang, Andreas Rimner, Abraham J Wu
- Abstract
Loading... -
+
MA02.07 - A Phase I Trial of an Immune Checkpoint Inhibitor Plus Stereotactic Ablative Radiotherapy in Patients with Early Stage Non-Small Cell Lung Cancer
11:10 - 11:15 | Presenter: Megan Eileen Daly | Author(s): Arta Monir Monjazeb, Amin Mirhadi, David Eastham, Frances Lara, Jonathan Wesley Riess, Ellen A Wiegner, Karen Kelly
- Abstract
Loading... -
+
MA02.08 - Discussant - MA02.05, MA02.06, MA02.07
11:15 - 11:30 | Presenter: Mireia Serra-Mitjans
- Abstract
No abstract available for this presentation
-
+
MA02.09 - Prognostic Impact of Immune Cell Biomarkers in Surgically Resectable Non-Small Cell Lung Cancer
11:30 - 11:35 | Presenter: Stephanie Tuminello | Author(s): Rajwanth Veluswamy, Francesca Petralia, Pei Wang, Raja Flores, Maaike Van Gerwen
- Abstract
Loading... -
+
MA02.10 - Different Prognostic Impact of Lymphovascular Invasion Between Lobectomy and Sublobar Resection in Stage IA Non-Small Cell Lung Cancer: A Propensity Score–Matched Analysis
11:35 - 11:40 | Presenter: Jae Kwang Yun | Author(s): Geun Dong Lee, Yooyoung Chong, Yong Ho Jeong, Sehoon Choi, Hyeong Ryul Kim, Yong-Hee Kim, Dong Kwan Kim, Seung-Il Park
- Abstract
Loading... -
+
MA02.11 - Adjuvant Chemotherapy Following SBRT for Early Stage Non-Small Cell Lung Cancer (NSCLC) in Older Patients
11:40 - 11:45 | Presenter: Apar Kishor Ganti | Author(s): Adams Kusi Appiah, Vinicius Ernani, Chi Zhang, Weining Zhen, Alissa Marr, Lynette Smith
- Abstract
Loading... -
+
MA02.12 - Discussant - MA02.09, MA02.10, MA02.11
11:45 - 12:00 | Presenter: Yaxing Shen
- Abstract
No abstract available for this presentation
-
+
MA03 - Clinomics and Genomics
- 10:30 - 12:00
- 9/08/2019
- Location: Colorado Springs (1994)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Advanced NSCLC
- Moderators:Heather A Wakelee, Wilfried Ernst Erich Eberhardt
-
+
MA03.01 - The Impact of Early Steroids on Clinical Outcomes in Patients with Advanced NSCLC Treated with Immune Checkpoint Inhibitors- A Cancerlinq Cohort
10:30 - 10:35 | Presenter: Nathan Pennell | Author(s): Pradnya Dinkar Patil, Xuefei Jia, Brian Hobbs
- Abstract
Loading... -
+
MA03.02 - Genetic Variants in ERAP1 and NCF2 in the MHC Class I Related Genes Are Associated with Non-Small Cell Lung Cancer Survival
10:35 - 10:40 | Presenter: Sen Yang | Author(s): Qingyi Wei, David C Christiani, Qiming Wang
- Abstract
Loading... -
+
MA03.03 - CEA and CYFRA 21-1 as Prognostic Biomarkers of Benefit from Nivolumab and as a Tool in Treatment Monitoring in Advanced NSCLC
10:40 - 10:45 | Presenter: Filippo Gustavo Dall'Olio | Author(s): Francesca Abbati, Francesco Facchinetti, Francesco Gelsomino, Barbara Melotti, Maria Massucci, Sebastiano Buti, Michele Veneziani, marcello Tiseo, Andrea Ardizzoni
- Abstract
Loading... -
+
MA03.04 - Discussant - MA03.01, MA03.02, MA03.03
10:45 - 11:00 | Presenter: Nathan Pennell
- Abstract
No abstract available for this presentation
-
+
MA03.05 - BRAF Mutations Are Associated with Increased Benefit from PD1/PDL1 Blockade Compared with Other Oncogenic Drivers in Non-Small Cell Lung Cancer
11:00 - 11:05 | Presenter: Marcelo Vailati Negrao | Author(s): Ferdinandos Skoulidis, Meagan Montesion, Katja Schulze, Ilze Bara, Vincent Shen, Sylvia Hu, Yasir Elamin, Xiuning Le, Michael E Goldberg, Chang-Jiun Wu, Jianhua Zhang, David S Barreto, Waree Rinsurongkawong, George R Simon, Jack Roth, Stephen Swisher, Jack Lee, Anne Tsao, Vassiliki A Papadimitrakopoulou, Don Lynn Gibbons, Bonnie Glisson, Vincent A Miller, Brian Alexander, Garrett M Frampton, Lee A Albacker, David S Shames, Jianjun Zhang, John Victor Heymach
- Abstract
Loading... -
+
MA03.06 - Efficacy Results of Selective AXL Inhibitor Bemcentinib with Pembrolizumab Following Chemotherapy in Patients with NSCLC
11:05 - 11:10 | Presenter: Enriqueta Felip | Author(s): Paal Brunsvig, Åslaug Helland, Nuria Viñolas, Santiago Ponce Aix, Enric Carcereny, Manuel Dómine, Jose Manuel Trigo Perez, Edurne Arriola, Rosario Garcia Campelo, James Spicer, Jonathan Robert Thompson, Ana Laura Ortega Granados, Robert J. Holt, Dominic Smethurst, James B. Lorens, Muhammad Shoaib, Abdul Siddiqui, Julia Schoelermann, Katherine Lorens, Emmett V. Schmidt, Michael Jon Chisamore, Matthew Krebs
- Abstract
Loading... -
+
MA03.07 - First-Line Atezolizumab Chemoimmunotherapy in Advanced Non-Squamous NSCLC Patients Harboring EGFR/ALK Genetic Alterations
11:10 - 11:15 | Presenter: Kyaw Zin Thein | Author(s): Nusrat Jahan, Aung Myint Tun, Anita Sultan, Sriman Swarup, Francis Mogollon-Duffo, Rachana Yendala, Miguel Quirch, Thura Win Htut, Nicholas D’cunha, Shabnam Rehman, Fred Hardwicke, Sanjay Awasthi, Lukman Tijani
- Abstract
Loading... -
+
MA03.08 - Discussant - MA03.05. MA03.06, MA03.07
11:15 - 11:30 | Presenter: Myung-Ju Ahn
- Abstract
No abstract available for this presentation
-
+
MA03.09 - Dramatic Responses to Immune Checkpoint Inhibitors in MET Exon 14 Skipping Mutation (METex14mut) Non Small Cell Lung Cancers
11:30 - 11:35 | Presenter: Marie Mayenga | Author(s): Isabelle Monnet, Marie-Ange Massiani, Jean-Baptiste Assié, Laure Tabeze, Sylvie Friard, Severine Fraboulet, Anne-Cécile Metivier, Christos Chouaid, Leila Zemoura, Elisabeth Longchampt, Samia Melaabi, Louis-Jean Couderc, Helene Doubre
- Abstract
Loading... -
+
MA03.10 - Prospective Evaluation of a Prognostic Clinico-Molecular Score (DEMo) to Predict Outcome of Advanced NSCLC Patients Treated with Immunotherapy
11:35 - 11:40 | Presenter: Arsela Prelaj | Author(s): Claudia Proto, Giuseppe Lo Russo, Diego Signorelli, Roberto Ferrara, Mavis Mensah, Giulia Galli, Alessandro De Toma, Giovanni Randon, Filippo Pagani, MARTA Brambilla, Benedetta Trevisan, Monica Ganzinelli, Nicoletta Zilembo, Filippo Guglielmo Maria De Braud, VALTER Torri, Marina Chiara Garassino, Gabriella Sozzi, Mattia Boeri
- Abstract
Loading... -
+
MA03.11 - Chemotherapy After PD-1 Inhibitors Versus Chemotherapy Alone in Patients with Non–Small Cell Lung Cancer (WJOG10217L)
11:40 - 11:45 | Presenter: Hirotsugu Kenmotsu | Author(s): Eriko Miyawaki, Ryoji Kato, Hidetoshi Hayashi, Yasutaka Chiba, Junichi Shimizu, Tomohiro Ozaki, Daichi Fujimoto, Ryo Toyozawa, Yuki Akazawa, Motoyasu Okuno, Sayako Morikawa, Tatsuo Ohira, Taishi Harada, Ryota Ushio, Akihito Kubo, Toshiyuki Harada, Nozomu Kimura, Hiroyuki Yamaguchi, Kazuo Nishikawa, Nobuyuki Yamamoto, Kazuhiko Nakagawa
- Abstract
Loading... -
+
MA03.12 - Discussant - MA03.09, MA03.10, MA03.11
11:45 - 12:00 | Presenter: HOWARD WEST
- Abstract
No abstract available for this presentation
-
+
MS01 - Immunotherapy Resistance
- 10:30 - 12:00
- 9/08/2019
- Location: San Francisco (2009)
- IASLC CME Accredited
- Type: Mini Symposium
- Track: Immuno-oncology
- Moderators:Ignacio Gil-Bazo, Nuria Viñolas
-
+
MS01.01 - Biological Mechanisms of Resistance
10:30 - 10:45 | Presenter: Justin F. Gainor
- Abstract
Loading... -
+
MS01.02 - Treatment Determining Markers - What Have We Achieved so Far?
10:45 - 11:00 | Presenter: Naiyer A Rizvi
- Abstract
Loading... -
+
MS01.03 - Overcoming Resistance - Clinical Results?
11:00 - 11:15 | Presenter: Ross Soo
- Abstract
Loading... -
+
MS01.04 - Smoking and Immunotherapy
11:15 - 11:30 | Presenter: Nise Yamaguchi
- Abstract
Loading... -
+
MS01.05 - Q&A
11:30 - 12:00
- Abstract
No abstract available for this presentation
-
+
MS02 - What Molecular Screening for Which Patients?
- 10:30 - 12:00
- 9/08/2019
- Location: Vienna (2016)
- IASLC CME Accredited
- Type: Mini Symposium
- Track: Targeted Therapy
- Moderators:Rosario Garcia Campelo, Santiago Ponce
-
+
MS02.01 - Platform Selection in an Era of Increasing Numbers and Types of Relevant Biomarkers
10:30 - 10:50 | Presenter: David P Carbone
- Abstract
Loading... -
+
MS02.02 - Liquid Biopsy: Who, When, What and How
10:50 - 11:10 | Presenter: Christian Rolfo
- Abstract
Loading... -
+
MS02.03 - Achieving Effective Lung Cancer Genotyping While Balancing Constrained Resources
11:10 - 11:30 | Presenter: Lynette M Sholl
- Abstract
Loading... -
+
MS02.04 - The Role of Molecular Board
11:30 - 11:50 | Presenter: Lara Pijuan
- Abstract
Loading... -
+
MS02.05 - Q&A
11:50 - 12:00
- Abstract
No abstract available for this presentation
-
+
OA01 - Advanced Diagnostic Approaches for Intrathoracic Lymph Nodes and Peripheral Lung Tumors
- 10:30 - 12:00
- 9/08/2019
- Location: Melbourne (1991)
- IASLC CME Accredited
- Type: Oral Session
- Track: Interventional Diagnostics/Pulmonology
- Moderators:Marioara Simon, Tim Murgu
-
+
OA01.01 - Predictive Value of EBUS Strain Elastography in Mediastinal Lymph Node Staging; The E-Predict Multicenter Study Results
10:30 - 10:40 | Presenter: Roel L.J. Verhoeven | Author(s): Rocco Trisolini, Fausto Leoncini, Michela Bezzi, Piero Candoli, Alessandro Messi, Mark Krasnik, Jouke Annema, Chris de Korte, Erik H.F.M. Van Der Heijden
- Abstract
Loading... -
+
OA01.02 - Endobronchial Ultrasound Staging of Operable NSCLC: Triple Negative Lymph Nodes May Not Require Routine Biopsy
10:40 - 10:50 | Presenter: Danielle Hylton | Author(s): Kaesavan Selvakumaran, Biniam Kidane, Jonathan D. Spicer, Simon R Turner, Daniel French, Chuck Wen, James Masters, Yogita S. Patel, Jenelle Taylor, Christian Finley, Yaron Shargall, Forough Farrokhyar, John Agzarian, Andrew Seely, Kazuhiro Yasufuku, Wael C. Hanna
- Abstract
Loading... -
+
OA01.03 - Probability Model for Malignancy in Hilar and Mediastinal Lymph Nodes in Lung Cancer Based on PET-CT and EBUS
10:50 - 11:00 | Presenter: Jaume Bordas-Martinez | Author(s): Jose Luis Vercher Conejero, Guillermo Rodríguez Gonzalez, Paula Notta, Cristian Tebé Cordomi, Cristina Martín Cabeza, Noelia Cubero De Frutos, María Rosa López-Lisbona, Marta Díez-Ferrer, Nuria Baixeras Gonzalez, Cristina Gamez Cenzano, Jordi Dorca Sargatal, Antoni Rosell
- Abstract
Loading... -
+
OA01.04 - Discussant - OA01.01, OA01.02, OA01.03
11:00 - 11:15 | Presenter: Rocco Trisolini
- Abstract
No abstract available for this presentation
-
+
OA01.05 - Cryobiopsy Compared with Forceps Biopsy in Pathological Diagnosis and Biomarker Research in Lung Cancer: A Prospective, Single-Arm Study
11:15 - 11:25 | Presenter: Tomoyuki Naito | Author(s): Hibiki Udagawa, Keisuke Kirita, Takaya Ikeda, Yoshitaka Zenke, Shingo Matsumoto, Kiyotaka Yoh, Seiji Niho, Genichiro Ishii, Koichi Goto
- Abstract
Loading... -
+
OA01.06 - Cone Beam CT Imaging for Transbronchial Navigation in Small Peripheral Pulmonary Lesions
11:25 - 11:35 | Presenter: Erik H.F.M. Van Der Heijden | Author(s): Roel L.J. Verhoeven, Jurgen Fütterer, Wouter Hoefsloot
- Abstract
Loading... -
+
OA01.07 - Ultrathin Bronchoscopy Combined with VBN and EBUS for the Diagnosis of PPLs With or Without Fluoroscopy: A Randomized Trial
11:35 - 11:45 | Presenter: Jiayuan Sun | Author(s): Xiaoxuan Zheng, Fangfang Xie
- Abstract
Loading... -
+
OA01.08 - Discussant - OA01.05, OA01.06, OA01.07
11:45 - 12:00 | Presenter: Mehrnaz Asadi
- Abstract
No abstract available for this presentation
-
+
OA02 - A New Vision of Targets and Strategies
- 10:30 - 12:00
- 9/08/2019
- Location: Seoul (2007)
- IASLC CME Accredited
- Type: Oral Session
- Track: Targeted Therapy
- Moderators:Frank Griesinger, Luis Paz-Ares
-
+
OA02.01 - Alectinib in Previously Treated RET-Rearranged Advanced Non-Small-Cell Lung Cancer: A Phase 1/2 Trial (ALL-RET)
10:30 - 10:40 | Presenter: Noriko Yanagitani | Author(s): Shinji Takeuchi, Toshinori Murayama, Kenichi Yoshimura, Yasuhito Imai, Shizuko Takahara, Takahiro Kawakami, Takashi Seto, Yoshihiro Hattori, Kadoaki Ohashi, Masahiro Morise, Shingo Matsumoto, Kiyotaka Yoh, Koichi Goto, Makoto Nishio, Seiji Yano
- Abstract
Loading... -
+
OA02.02 - Phase 1 Study of Safety, Tolerability, PK and Efficacy of AMG 510, a Novel KRAS G12C Inhibitor, Evaluated in NSCLC
10:40 - 10:50 | Presenter: Ramaswamy Govindan | Author(s): Marwan G Fakih, Timothy J Price, Gerald S Falchook, Jayesh Desai, James C Kuo, John H Strickler, John C Krauss, Bob T Li, Crystal S Denlinger, Greg Durm, Jude Ngang, Haby Henary, Gataree Ngarmchamnanrith, Erik Rasmussen, Phuong Khanh Morrow, David S. Hong
- Abstract
Loading... -
+
OA02.03 - The Third Generation EGFR Inhibitor (EGFR-TKI) HS-10296 in Advanced NSCLC Patients with Resistance to First Generation EGFR-TKI
10:50 - 11:00 | Presenter: Shun Lu | Author(s): Qiming Wang, Guojun Zhang, Xiaorong Dong, Cheng-Ta Yang, Yong Song, Gee-Chen Chang, You Lu, Hongming Pan, Chao-Hua Chiu, Zhehai Wang, Jifeng Feng, Jianying Zhou, Xingxiang Xu, Renhua Guo, Jianhua Chen, Haihua Yang, Yuan Chen, Zhuang Yu, Her-Shyong Shiah, Chin-Chou Wang, Nong Yang, Jian Fang, Ping Wang, Kai Wang, Yanping Hu, Jianxing He, Ziping Wang, Jianhua Shi, Shaoshui Chen, Ying Cheng, Wu-Chou Su, Te-Chun Hsia, Jiuwei Cui, yuping Sun, Chih-Hsin Yang
- Abstract
Loading... -
+
OA02.04 - Discussant - OA02.01, OA02.02, OA02.03
11:00 - 11:15 | Presenter: Jon Zugazagoitia
- Abstract
No abstract available for this presentation
-
+
OA02.05 - First-In-Human Phase 1/2 Trial of Anti-AXL Antibody–Drug Conjugate (ADC) Enapotamab Vedotin (EnaV) in Advanced NSCLC
11:15 - 11:25 | Presenter: Suresh S Ramalingam | Author(s): Juanita Lopez, Morten Mau-Sorensen, Fiona Thistlethwaite, Sarina Piha-Paul, Shirish Gadgeel, Yvette Drew, Pasi A Jänne, Aaron S. Mansfield, Guang Chen, Ulf Forssmann, Hrefna Kristin Johannsdottir, Nora Pencheva, Annette Ervin-Haynes, Ignace Vergote
- Abstract
Loading... -
+
OA02.06 - The Sequential Therapy of Crizotinib Followed by Alectinib: Real World Data of 840 Patients with NSCLC Harboring ALK-Rearrangement (WJOG9516L)
11:25 - 11:35 | Presenter: Satomi Watanabe | Author(s): Takeharu Yamanaka, Kentaro Ito, Shinya Sakata, Haruko Daga, Takashi Kijima, Katsuya Hirano, Isamu Okamoto, Atsushi Nakamura, TOSHIYUKI Kozuki, Mikiko Ishihara, Koichi Azuma, Takashi Seto, Toshihide Yokoyama, Yuko Oya, Haruki Kobayashi, Kazumi Nishino, Yoshihiro Hattori, Kazuhiko Nakagawa, Nobuyuki Yamamoto
- Abstract
Loading... -
+
OA02.07 - Phase 3 ALUR Study of Alectinib in Pretreated ALK+ NSCLC: Final Efficacy, Safety and Targeted Genomic Sequencing Analyses
11:35 - 11:45 | Presenter: Juergen Wolf | Author(s): Åslaug Helland, In-Jae Oh, Maria Rita Migliorino, Rafal Dziadziuszko, Javier De Castro Carpeno, Julien Mazieres, Frank Griesinger, Marijana Chlistalla, Andres Cardona, Thorsten Ruf, Kerstin Trunzer, Vlatka Smoljanovic, Silvia Novello
- Abstract
Loading... -
+
OA02.08 - Discussant - OA02.05, OA02.06, OA02.07
11:45 - 12:00 | Presenter: Michael Duruisseaux
- Abstract
No abstract available for this presentation
-
+
YI03 - Scientific Mentoring
- 10:30 - 12:00
- 9/08/2019
- Location: Dublin (1997)
- IASLC CME Accredited
- Type: Young Investigator Session
- Track: Young Investigators
- Moderators:Lizza Hendriks, Carme Obiols
-
+
Introduction/Poll
10:30 - 10:30
- Abstract
No abstract available for this presentation
-
+
YI03.01 - Why to Apply for International Fellowship?
10:30 - 10:50 | Presenter: Celine Mascaux
- Abstract
Loading... -
+
YI03.02 - How to Apply for International Fellowship?
10:50 - 11:10 | Presenter: Ming Sound Tsao
- Abstract
Loading... -
+
YI03.03 - Scientific Mentorship: What Should You Expect?
11:10 - 11:30 | Presenter: Rafael Rosell
- Abstract
Loading... -
+
YI03.04 - Oncology Fellows' Career Plans and Expectations
11:30 - 11:50 | Presenter: Masaoki Ito
- Abstract
Loading... -
+
YI03.05 - Q&A
11:50 - 12:00
- Abstract
No abstract available for this presentation
-
+
EXH01 - Bristol-Myers Squibb Foundation Exhibit Showcase Session - Adressing Inequities in Care and Support for Lung Cancer Patients In The Us and Africa: Lessons and Challenges From the Front Lines
- 12:00 - 13:15
- 9/08/2019
- Location: Exhibit Hall
- Type: Industry Symposia & Workshops
- Track:
-
+
EXH01.01 - Registration & Lunch
12:00 - 12:10
- Abstract
No abstract available for this presentation
-
+
EXH01.02 - Host Opening Remarks
12:10 - 12:13 | Presenter: Catharine Grimes
- Abstract
No abstract available for this presentation
-
+
EXH01.03 - Moderator Opening Remarks
12:13 - 12:20 | Presenter: Christopher S Lathan
- Abstract
No abstract available for this presentation
-
+
EXH01.04 - Lung Cancer Screening: Are we ready? Educating providers and increasing awareness about their role in lung cancer screening. Lessons from the LuCa National Training Network in the US.
12:20 - 12:28 | Presenter: Celeste T Worth
- Abstract
No abstract available for this presentation
-
+
EXH01.05 - Establishing a Pan-African collaboration to improve awareness about, data on and intervention for lung cancer. How Secure The Future is trying to rapidly build an African body of knowledge regarding lung cancer in different cultural and resource settings; health systems and within sites with varying risk-profiles and economic development
12:28 - 12:36 | Presenter: Fredrick Chite Asirwa
- Abstract
No abstract available for this presentation
-
+
EXH01.06 - How do we track it? The VAPALS-ELCAP Open Source Lung Screening Management System: Implications for Global Partnerships to Improve Lung Screening Access, Safety, and Efficacy
12:36 - 12:44 | Presenter: Drew Moghanaki
- Abstract
No abstract available for this presentation
-
+
EXH01.07 - Planning for Survivors: Building Support Services and Survivorship Pathways for Patients Treated for Lung Cancer
12:44 - 12:52 | Presenter: Scott Shofer
- Abstract
No abstract available for this presentation
-
+
EXH01.08 - Putting it All Together - The Optimal Care Coordination Model (OCCM): The goal of this project is to create sustainable improvements in Medicaid patients’ access to quality lung cancer services and health outcomes by developing a comprehensive, written plan delineating a Medicaid lung cancer patient’s course of treatment and progression using an OCCM for providers, patients and their caregivers
12:52 - 13:00 | Presenter: Matthew P Smeltzer
- Abstract
No abstract available for this presentation
-
+
EXH01.09 - Moderated Discussion and Q&A
13:00 - 13:10 | Presenter: Christopher S Lathan
- Abstract
No abstract available for this presentation
-
+
EXH01.10 - Closing Remarks
13:10 - 13:10 | Presenter: Catharine Grimes
- Abstract
No abstract available for this presentation
-
+
IS09 - Symposium by Physicians' Education Resource, LLC (PER): Leveraging The Lung Cancer Team In Stage III NSCLC With Immuno-Oncology Strategies (Not IASLC CME Accredited)
- 12:00 - 13:30
- 9/08/2019
- Location: Barcelona (2005)
- Type: Industry Symposia & Workshops
- Track:
-
+
ES06 - New Approaches in Second Line Treatment In NSCLC
- 13:30 - 15:00
- 9/08/2019
- Location: Vienna (2016)
- IASLC CME Accredited
- Type: Educational Session
- Track: Advanced NSCLC
- Moderators:Susana Cedres, Oliver Gautschi
-
+
Introduction/Poll
13:30 - 13:30
- Abstract
No abstract available for this presentation
-
+
ES06.01 - Recent Advances in Second Line Treatment
13:30 - 13:50 | Presenter: Roy S. Herbst
- Abstract
Loading... -
+
ES06.02 - What Is the Best Strategy in Progressive Disease After Consolidation with Durvalumanb, or Rapid Progressors to First Line?
13:50 - 14:10 | Presenter: Fabrice Barlesi
- Abstract
Loading... -
+
ES06.03 - Future Strategies in Second Line Treatment
14:10 - 14:30 | Presenter: Gregory J Riely
- Abstract
Loading... -
+
ES06.04 - The Best Treatment Sequence for Advanced NSCLC EGFR/ALK/ROS/BRAF wt
14:30 - 14:50 | Presenter: Juergen Wolf
- Abstract
Loading... -
+
ES06.05 - Q&A
14:50 - 15:00
- Abstract
No abstract available for this presentation
first
prev
